A new study reports that nanomolar GenX exposure reduces viability, triggers caspase-3- and PARP-associated apoptosis, raises ...

Men who receive testosterone replacement therapy had an increased rate of favorable-risk prostate cancer compared to those who did not use the therapy, and a decreased rate of aggressive prostate ...

Newswise — Preliminary research suggests that testosterone replacement therapy for men with low testosterone levels appears to have little effect on the prostate gland, contrary to some reports that ...

In a population of middle-aged and older men with hypogonadism, "the incidences of high-grade or any prostate cancer and other prostate events were low and did not differ significantly between ...

Testosterone replacement therapy (TRT) is indicated in hypogonadal symptomatic men, where contraindications to treatment do not exist. The International Society for the Study of the Aging Male ...

The results of the present study showed that TRT of 1 year of duration did not effect PSA levels significantly (most PSA rise below 0.5 ng/ml) with regard to age and the mode of the therapy either ...

Preliminary research suggests that testosterone replacement therapy for men with low testosterone levels appears to have little effect on the prostate gland, contrary to some reports that this therapy ...